Results for:(80 found)
May 7, 2013 9:02AM on Top StocksBy Jim Cramer

It may be time to move money out of some industries and into others, but which stocks to choose?

May 3, 2013 9:08AM on Top StocksBy Jim Cramer

Unlike biotechs, many of these companies are pouring money into share buybacks -- instead of their long-term pipelines.

Apr 25, 2013 9:37AM on Top StocksBy Jim Cramer

The only explanation for recent stock action is market players following others blindly. The bulls just have to hope analysts don't think this is National Lemming Week.

Apr 11, 2013 12:24PM on Top StocksBy 247 Wall St.

Investors can still find some compelling valuations among large-cap drug companies even as major stock indices hit new highs.

Mar 20, 2013 9:43AM on Top StocksBy Stock Traders Daily

Despite trading near its 52-week high, the stock appears to have plenty left.

Mar 18, 2013 9:19AM on Top StocksBy Jim Cramer

The deal will likely not wipe out all the recent gains as some now warn, but some profit taking is prudent.

Mar 8, 2013 10:23AM on Top StocksBy TheStockAdvisors

By choosing stocks from different payment periods, you can collect dividends every month.

Mar 8, 2013 10:17AM on Top StocksBy Stock Traders Daily

Patent expirations are contributing to M&A fever in the biotech sector.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More